Rhenium(RE-186) Obisbemeda{RE-186 nanoliposome (186RNL)}in Leptomeningeal Metastasis [LM] Phase 1/2A Dose Escalation Trial: Update of Initial Safety and Feasibility Through Cohorts 1-4
07:30am - 03:35pm EDT - April 5, 2024